Literature DB >> 24221620

[Psychopharmacotherapy in emergency medicine].

A Wolf1, M J Müller, F-G B Pajonk.   

Abstract

Part two of the CME article Psychotropic agents and psychopharmacotherapy in emergency medicine aims to give an understanding of the pharmacotherapy of psychiatric disorders in emergency medicine. In contrast to somatic emergencies, many emergency physicians are not familiar with the treatment of psychiatric emergencies, although there are guidelines and recommendations. In the following article, treatment recommendations for the 5 most common and relevant syndromes in emergency medicine (i.e., suicide, delirium, agitation, stupor, and syndromes due to psychopharmaceutical use) are described based on the German S2-Guideline Emergency Psychiatry that will be published soon.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24221620     DOI: 10.1007/s00063-013-0318-z

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  35 in total

1.  Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia.

Authors:  P Wright; M Birkett; S R David; K Meehan; I Ferchland; K J Alaka; J C Saunders; J Krueger; P Bradley; L San; M Bernardo; M Reinstein; A Breier
Journal:  Am J Psychiatry       Date:  2001-07       Impact factor: 18.112

2.  The use of midazolam in acutely agitated psychiatric patients.

Authors:  M Wyant; B I Diamond; E O'Neal; A Sloan; R L Borison
Journal:  Psychopharmacol Bull       Date:  1990

3.  Intramuscular flunitrazepam versus intramuscular haloperidol in the emergency treatment of aggressive psychotic behavior.

Authors:  A Dorevitch; N Katz; Z Zemishlany; D Aizenberg; A Weizman
Journal:  Am J Psychiatry       Date:  1999-01       Impact factor: 18.112

Review 4.  Pathophysiology and management of the serotonin syndrome.

Authors:  T M Brown; B P Skop; T R Mareth
Journal:  Ann Pharmacother       Date:  1996-05       Impact factor: 3.154

5.  Rapid tranquilization: a comparison of thiothixene with loxapine.

Authors:  W R Dubin; K J Weiss
Journal:  J Clin Psychiatry       Date:  1986-06       Impact factor: 4.384

6.  Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study.

Authors:  J Battaglia; S Moss; J Rush; J Kang; R Mendoza; L Leedom; W Dubin; C McGlynn; L Goodman
Journal:  Am J Emerg Med       Date:  1997-07       Impact factor: 2.469

Review 7.  [Lengthening of QT interval by antipsychotic drugs].

Authors:  W Haverkamp; M Deuschle
Journal:  Nervenarzt       Date:  2006-03       Impact factor: 1.214

8.  Efficacy of ziprasidone against hostility in schizophrenia: Post hoc analysis of randomized, open-label study data.

Authors:  Leslie Citrome; Jan Volavka; Pal Czobor; Shlomo Brook; Antony Loebel; Francine S Mandel
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

9.  ECT in the treatment of a patient with catatonia: consent and complications.

Authors:  Marc H Zisselman; Richard L Jaffe
Journal:  Am J Psychiatry       Date:  2010-02       Impact factor: 18.112

10.  Intramuscular aripiprazole in the control of agitation.

Authors:  Glenn W Currier; Leslie L Citrome; Dan L Zimbroff; Dan Oren; George Manos; Robert McQuade; Andrei A Pikalov; David T Crandall
Journal:  J Psychiatr Pract       Date:  2007-05       Impact factor: 1.325

View more
  1 in total

1.  [Comparison of sublingual and intravenous administration of lorazepam in psychiatric emergencies in emergency medical services].

Authors:  D Schwerthöffer; F-G Pajonk
Journal:  Anaesthesist       Date:  2018-12-06       Impact factor: 1.041

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.